Academisch Medisch Centrum Universiteit van Amsterdam

back

2010

• Heutinck KM, ten Berge IJM, Hack CE, Hamann J, Rowshani AT. Serine proteases of the human immune system in health and disease. MOL IMMUNOL 2010;47(11-12):1943-1955.   [ PubMed ]
• Kers J, Xu-Dubois YC, Rondeau E, Claessen N, Idu MM, Roelofs JJTH, Bemelman FJ, ten Berge IJM, Florquin S. Intragraft Tubular Vimentin and CD44 Expression Correlate With Long-Term Renal Allograft Function and Interstitial Fibrosis and Tubular Atrophy. TRANSPLANTATION 2010; [aheadofprint]   [ PubMed ]
• Rombach SM, Baas MC, ten Berge IJM, Krediet RT, Bemelman FJ, Hollak CEM. The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease. NEPHROL DIAL TRANSPL 2010; [aheadofprint]   [ PubMed ]
• Struijk GH, Minnee RC, Koch SD, Zwinderman AH, van Donselaar-van der Pant KAMI, Idu MM, ten Berge IJM, Bemelman FJ. Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses. KIDNEY INT 2010; [aheadofprint]   [ PubMed ]
• van de Berg PJ, Heutinck KM, Raabe R, Minnee RC, Young SL, van Donselaar-van der Pant KA, Bemelman FJ, van Lier RA, ten Berge IJ. Human Cytomegalovirus Induces Systemic Immune Activation Characterized by a Type 1 Cytokine Signature. J INFECT DIS 2010;202(5):690-699.   [ PubMed ]
• van de Berg PJEJ, Griffiths SJ, Yong SL, Macaulay R, Bemelman FJ, Jackson S, Henson SM, ten Berge IJM, Akbar AN, van Lier RAW. Cytomegalovirus Infection Reduces Telomere Length of the Circulating T Cell Pool. J IMMUNOL 2010;184(7):3417-3423.   [ PubMed ]
• van Ham SM, Heutinck KM, Jorritsma T, Bemelman FJ, Strik MCM, Vos W, Muris JJF, Florquin S, ten Berge IJM, Rowshani AT. Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients. KIDNEY INT 2010; [aheadofprint]   [ PubMed ]

2009

• Baas MC, van Donselaar KAMI, Florquin S, van Binnendijk RS, ten Berge IJM, Bemelman FJ. Mumps: Not an Innocent Bystander in Solid Organ Transplantation. AM J TRANSPLANT 2009;9(9):2186-2189.   [ PubMed ]
• Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW. Minimization of Maintenance Immunosuppression Early After Renal Transplantation: An Interim Analysis. TRANSPLANTATION 2009;88(3):421-428.   [ PubMed ]
• de Kruif MD, Limper M, Hansen HR, de Ruiter J, Spek CA, van Gorp ECM, ten Berge IJ, Rowshani AT, ten Cate H, Meesters EW. Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus. ANN RHEUM DIS 2009;68(10):1654.   [ PubMed ]
• Hodiamont CJ, Dolman KM, ten Berge IJM, Melchers WJG, Verweij PE, Pajkrt D. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. MED MYCOL 2009;47(2):217-220.   [ PubMed ]
• Minnee RC. Surgical aspects of renal transplantation. s.l.: s.n.; 2009. (109pp.) (ISBN 9789085595724) (PhD thesis. Supervisor(s): Legemate DA, ten Berge RJM; co-supervisor(s): Idu MM, Bemelman FJ)   [ UvA Dissertations Online ]
• Minnee RC, Bemelman FJ, Laguna Pes PP, ten Berge IJM, Legemate DA, Idu MM. Effectiveness of a 5-Day External Stenting Protocol on Urological Complications After Renal Transplantation. WORLD J SURG 2009;33(12):2722-2726.   [ PubMed ]
• Rowshani AT, Lardy NM, Surachno JS, ten Berge RJM. Humorale immuniteit en niertransplantatie. Mogelijkheden van desensibilisatiebehandeling. NED TIJDSCHR GENEESKD 2009;153(13):612-616.   [ PubMed ]
• van den Berg TJ, Bogers H, Vriesendorp TM, Surachno JS, DeVries JH, ten Berge IJ, Hoekstra JBL. No apparent impact of increased post-operative blood glucose levels on clinical outcome in kidney transplant recipients. CLIN TRANSPLANT 2009;23(2):256-263.   [ PubMed ]
• Yapici U, Bemelman FJ, Scheepstra CG, Roelofs JJTH, Claessen N, van der Loos C, van Donselaar-van der Pant K, Bouts AHM, Idu MM, Rowshani AT, ten Berge IJM, Florquin S. Intragraft FOXP3 Protein or mRNA During Acute Renal Allograft Rejection Correlates With Inflammation, Fibrosis, and Poor Renal Outcome. TRANSPLANTATION 2009;87(9):1377-1380.   [ PubMed ]

2008

• Bemelman FJ, ten Berge RJM. Late complicaties na niertransplantatie. NED TIJDSCHR GENEESKD 2008;152(23):1317-1321.   [ PubMed ]
• Brosens LAA, Tytgat KMAJ, Morsink FHM, Sinke RJ, ten Berge IJM, Giardiello FM, Offerhaus GJA, Keller JJ. Multiple colorectal neoplasms in X-linked agammaglobulinemia. CLIN GASTROENTEROL H 2008;6(1):115-119.   [ PubMed ]
• Koch SD, Uss E, van Lier RAW, ten Berge IJM. Alloantigen-induced regulatory CD8+CD103+ T cells. HUM IMMUNOL 2008;69(11):737-744.   [ PubMed ]
• Minnee RC, Bemelman F, Kox C, Surachno S, ten Berge IJM, Bemelman WA, Idu MM. Comparison of hand-assisted laparoscopic and open donor nephrectomy in living donors. INT J UROL 2008;15(3):206-209.   [ PubMed ]
• Minnee RC, Surachno S, Bemelman F, ten Berge IJM, Kox C, Legemate DA, Idu MM. Impact of additional vascular reconstructions on survival of kidney transplants. INT SURG 2008;93(2):111-115.   [ PubMed ]
• Nikolaeva N, Bemelman FJ, Yong SL, Verschuur A, van Lier RAW, ten Berge IJM. The pyrimidin analogue cyclopentenyl cytosine induces alloantigen-specific non-responsiveness of human T lymphocytes. CLIN EXP IMMUNOL 2008;151(2):348-358.   [ PubMed ]
• Rowshani AT, Bemelman FJ, Lardy NM, ten Berge IJM. Humoral immunity in renal transplantation: clinical significance and therapeutic approach. CLIN TRANSPLANT 2008;22(6):689-699.   [ PubMed ]
• Sankatsing SUC, Prins JM, Yong SLL, Roelofsen J, van Kuilenburg ABP, Kewn S, Back DJ, Bemelman FJ, ten Berge IJM. Mycophenolate mofetil inhibits T-cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP. TRANSPL INT 2008;21(11):1066-1071.   [ PubMed ]
• Scheepstra C, Bemelman FJ, van der Loos C, Rowshani AT, van Donselaar-van der Pant KAMI, Idu MM, ten Berge IJM, Florquin S. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. TRANSPLANTATION 2008;86(6):772-778.   [ PubMed ]
• ten Berge IJM, van Lier RAW. Attack of the CD4 clones. BLOOD 2008;111(4):1750-1751.
• van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. Cytotoxic human CD4(+) T cells. CURR OPIN IMMUNOL 2008;20(3):339-343.   [ PubMed ]
• van de Berg PJEJ, van Stijn A, ten Berge IJM, van Lier RAW. A fingerprint left by cytomegalovirus infection in the human T cell compartment. J CLIN VIROL 2008;41(3):213-217.   [ PubMed ]
• van Stijn A, Rowshani AT, Yong SL, Baas F, Roosnek E, ten Berge IJM, van Lier RAW. Human cytomegalovirus infection induces a rapid and sustained change in the expression of NK cell receptors on CD8+ T cells. J IMMUNOL 2008;180(7):4550-4560.   [ PubMed ]
• Vedder AC. Fabry disease. Challenges in relation to optimization of enzyme replacement therapy. s.l.: s.n.; 2008. (192pp.) (ISBN 9789090226637) (PhD thesis. Supervisor(s): Aerts JMFG, ten Berge RJM; co-supervisor(s): Hollak CEM)   [ UvA Dissertations Online ]
• Vedder AC, Breunig F, Donker-Koopman WE, Mills K, Young E, Winchester B, ten Berge IJM, Groener JEM, Aerts JMFG, Wanner C, Hollak CEM. Treatment of Fabry disease with different dosing regimens of agalsidase: effects on antibody formation and GL-3. MOL GENET METAB 2008;94(3):319-325.   [ PubMed ]

2007

• Alves NL, van Leeuwen EMM, Remmerswaal EBM, Vrisekoop N, Tesselaar K, Roosnek E, ten Berge IJM, van Lier RAW. A new subset of human naive CD8+ T cells defined by low expression of IL-7R alpha. J IMMUNOL 2007;179(1):221-228.   [ PubMed ]
• Day EK, Carmichael AJ, ten Berge IJM, Waller ECP, Sissons JGP, Wills MR. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J IMMUNOL 2007;179(5):3203-3213.   [ PubMed ]
• de Bree GJ, van Leeuwen EMM, ten Berge RJM. Immunologische afweer tegen virale infecties: virusspecifieke T-cellen in beeld. NED TIJDSCHR GENEESKD 2007;151(44):2440-2444.   [ PubMed ]
• Meesters EW, Hansen H, Spronk HMH, Hamulyak K, Rosing J, Rowshani AT, ten Berge IJM, ten Cate H. The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. BLOOD COAGUL FIBRIN 2007;18(1):21-28.   [ PubMed ]
• Nikolaeva NV. Phenopypic and functional characterization of the CD4 positive and CD8 positive allorepertoire. s.l.: s.n.; 2007. (143pp.) (ISBN 9789090221618) (PhD thesis. Supervisor(s): ten Berge RJM, van Lier RAW)   [ UvA Dissertations Online ]
• Uss E, Yong SL, Hooibrink B, van Lier RAW, ten Berge IJM. Rapamycin enhances the number of alloantigen-induced human CD103+CD8+ regulatory T cells in vitro. TRANSPLANTATION 2007;83(8):1098-1106.   [ PubMed ]
• van Leeuwen EMM, ten Berge IJM, van Lier RAW. Induction and maintenance of CD8+ T cells specific for persistent viruses. ADV EXP MED BIOL 2007;590:121-137.   [ PubMed ]
• van Leeuwen EMM, van Lier RAW, ten Berge IJA. Response to comment on "differential usage of cellular niches by cytomegalovirus versus EBV and influenza virus-specific CDB+ T cells". J IMMUNOL 2007;178(5):2612.

2006

• Bonarius HPJ, Baas F, Remmerswaal EBM, van Lier RAW, ten Berge IJM, Tak PP, de Vries N. Monitoring the T-cell receptor repertoire at single-clone resolution. PLOS ONE 2006;1:e55.   [ PubMed ]
• Demirtaş-Ertan G, Rowshani AT, ten Berge IJM. Azathioprine-induced shock in a patient suffering from undifferentiated erosive oligoarthritis. NETH J MED 2006;64(4):124-126.   [ PubMed ]
• Langeveld M, Gamadia LE, ten Berge IJM. T-lymphocyte subset distribution in human spleen. EUR J CLIN INVEST 2006;36(4):250-256.   [ PubMed ]
• Minnee RC, Surachno S, Kox C, ten Berge IJM, Aronson DC, Idu MM. Is a selective splinted ureterocystostomy protocol feasible in renal transplantation? An analysis of 475 renal transplantations. TRANSPL INT 2006;19(7):558-562.   [ PubMed ]
• Nikolaeva N, Bemelman FJ, Yong SL, van Lier RAW, ten Berge IJM. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells. TRANSPLANTATION 2006;81(3):445-454.   [ PubMed ]
• Rouschop KMA, Roelofs JJTH, Sylva M, Rowshani AT, ten Berge IJM, Weening JJ, Florquin S. Renal expression of CD44 correlates with acute renal allograft rejection. KIDNEY INT 2006;70(6):1127-1134.   [ PubMed ]
• Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, van Groningen MCR, Surachno JS, Mallat MJK, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. J AM SOC NEPHROL 2006;17(1):305-312.   [ PubMed ]
• Scholten EM, Rowshani AT, Cremers S, Bemelman FJ, Eikmans M, van Kan E, Mallat MJ, Florquin S, Surachno J, ten Berge IJ, Bajema IM, de Fijter JW. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J AM SOC NEPHROL 2006;17(9):2622-2632.   [ PubMed ]
• Uss AI. The ins and outs of CD103+CD8+ alloreactive regulatory T cells. S.l.: s.n.; 2006. (134pp.) (ISBN 90-9020956-5) (PhD thesis. Supervisor(s): ten Berge RJM, van Lier RAW)   [ UvA Dissertations Online ]
• Uss E, Rowshani AT, Hooibrink B, Lardy NM, van Lier RAW, ten Berge IJM. CD103 is a marker for alloantigen-induced regulatory CD8+ T cells. J IMMUNOL 2006;177(5):2775-2783.   [ PubMed ]
• van Leeuwen EMM, de Bree GJ, ten Berge IJM, van Lier RAW. Human virus-specific CD8+ T cells: diversity specialists. IMMUNOL REV 2006;211:225-235.   [ PubMed ]
• van Leeuwen EMM, Koning JJ, Remmerswaal EBM, van Baarle D, van Lier RAW, ten Berge IJM. Differential usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells. J IMMUNOL 2006;177(8):4998-5005.   [ PubMed ]
• van Leeuwen EMM, Remmerswaal EBM, Heemskerk MHM, ten Berge IJM, van Lier RAW. Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. BLOOD 2006;108(9):3121-3127.   [ PubMed ]

2005

• Bade B, Lohrmann J, ten Brinke A, Wolbink AM, Wolbink GJ, ten Berge IJM, Virchow JC Jr, Luttmann W, Hack CE. Detection of soluble human granzyme K in vitro and in vivo. EUR J IMMUNOL 2005;35(10):2940-2948.   [ PubMed ]
• Bemelman F, Yong SL, Tissingh R, Schellekens P, ten Berge I. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round. TRANSPL INT 2005;18(4):423-428.   [ PubMed ]
• Bermond B, Surachno S, Lok A , ten Berge IJM, Plasmans B, Kox C, Schuller E, Schellekens PTA, Hamel R. Memory functions in prednisone-treated kidney transplant patients. CLIN TRANSPLANT 2005;19(4):512-517.   [ PubMed ]
• Hack CE, Hamann-Wenzlau D, ten Berge RJM. Immunopathologie. In: van der Meer J, Stehouwer CDA, editors. Interne geneeskunde; 13e herz. dr. Houten: Bohn Stafleu Van Loghum; 2005. p. 87-118.
• Oud KTM, Bresser P, ten Berge RJM, Jonkers RE. The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. LUPUS 2005;14(12):959-963.   [ PubMed ]
• Rouschop KMA, Roelofs JJTH, Rowshani AT, Leemans JC, van der Poll T, ten Berge IJM, Weening JJ, Florquin S. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograft rejection. NEPHROL DIAL TRANSPL 2005;20(10):2248-2254.   [ PubMed ]
• Rowshani AT. Immunomodulation in renal transplanr recipidient. S.l.: s.n.; 2005. (158pp.) (ISBN 90-9019387-1) (PhD thesis. Supervisor(s): ten Berge RJM)   [ UvA Dissertations Online ]
• Rowshani AT, Bemelman FJ, van Leeuwen EMM, van Lier RAW, ten Berge IJM. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. TRANSPLANTATION 2005;79(4):381-386.   [ PubMed ]
• Rowshani AT, Strik MCM, Molenaar R, Yong SL, Wolbink AM, Bemelman FJ, Hack CE, ten Berge IJM. The granzyme B inhibitor SERPINB9 (protease inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation. J INFECT DIS 2005;192(11):1908-1911.   [ PubMed ]
• van Leeuwen EMM. Induction and maintenance of human virus-specific T cells. S.l.: s.n.; 2005. (180pp.) (ISBN 90-9020200-5) (PhD thesis. Supervisor(s): ten Berge RJM, van Lier RAW)   [ UvA Dissertations Online ]
• van Leeuwen EMM, de Bree GJ, Remmerswaal EBM, Yong SL, Tesselaar K, ten Berge IJM, van Lier RAW. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. BLOOD 2005;106(6):2091-2098.   [ PubMed ]
• van Leeuwen EMM, van Buul JD, Remmerswaal EBM, Hordijk PL, ten Berge IJM, van Lier RAW. Functional re-expression of CCR7 on CMV-specific CD8+ T cells upon antigenic stimulation. INT IMMUNOL 2005;17(6):713-719.   [ PubMed ]

2004

• Bemelman F, de Blok K, de Vries P, Surachno S, ten Berge I. Falciparum malaria transmitted by a thick blood smear negative kidney donor. SCAND J INFECT DIS 2004;36(10):769-771.   [ PubMed ]
• de Metz J, Romijn JA, Endert E, Ackermans MT, Weverling GJ, Busch OR, de Wit LT, Gouma DJ, ten Berge IJM, Sauerwein HP. Interferon-gamma increases monocyte HLA-DR expression without effects on glucose and fat metabolism in postoperative patients. J APPL PHYSIOL 2004;96(2):597-603.   [ PubMed ]
• Gamadia LE, Remmerswaal EB, Surachno S, Lardy NM, Wertheim-van Dillen PM, van Lier RAW, ten Berge IJM. Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules. TRANSPLANTATION 2004;77(12):1879-1885.   [ PubMed ]
• Gamadia LE, Rentenaar RJ, van Lier RAW, ten Berge IJM. Properties of CD4(+) T cells in human cytomegalovirus infection. HUM IMMUNOL 2004;65(5):486-492.   [ PubMed ]
• Gamadia LE, van Leeuwen EMM, Remmerswaal EBM, Yong SL, Surachno S, Wertheim-van Dillen PME, ten Berge IJM, van Lier RAW. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J IMMUNOL 2004;172(10):6107-6114.   [ PubMed ]
• Nikolaeva N, Uss E, van Leeuwen EMM, van Lier RAW, ten Berge IJM. Differentiation of human alloreactive CD4+ and CD8+ T cells in vitro. TRANSPLANTATION 2004;78(6):815-824.   [ PubMed ]
• Rentenaar RJ, Heydendael VMR, van Diepen FNJ, de Rie MA, ten Berge IJM. Systemic treatment with either cyclosporin A or methotrexate does not influence the T helper 1/T helper 2 balance in psoriatic patients. J CLIN IMMUNOL 2004;24(4):361-369.   [ PubMed ]
• Rowshani AT, Florquin S, Bemelman F, Kummer JA, Hack CE, ten Berge IJM. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: A potential mechanism for stable renal function in patients with subclinical rejection. KIDNEY INT 2004;66(4):1417-1422.   [ PubMed ]
• Rowshani AT, Schot LJ, ten Berge IJM. c-ANCA as a serological pitfall. LANCET 2004;363(9411):782.   [ PubMed ]
• Rowshani AT, Uss A, Yong SL, van Lier RAW, ten Berge IJM. Effects of CD25 monoclonal antibody on proliferative and effector functions of alloactivated human T cells in vitro. EUR J IMMUNOL 2004;34(3):882-899.   [ PubMed ]
• ten Berge IJM. De patiënt met verminderde afweer. In: Gans ROB, Hoorntje SJ, Strack van Schijndel RJM, editors. Consultatieve inwendige geneeskunde. Houten: Bohn Stafleu Van Loghum; 2004. p. 21-36.
• ten Berge RJM. Immunodeficiënties. In: Bijlsma JWJ, Geusens PPMM, Kallenberg CGM, Tak PP, editors. Reumatologie en klinische immunologie. Houten: Bohn Stafleu Van Loghum; 2004. p. 251-267.
• ten Berge RJM, Kallenberg CGM. Overgevoeligheidsreacties. In: Bijlsma JWJ, Geusens PPMM, Kallenberg CGM, Tak PP, editors. Reumatologie en klinische immunologie. Houten: Bohn Stafleu Van Loghum; 2004. p. 268-277.
• van Leeuwen EMM, Remmerswaal EBM, Vossen MTM, Rowshani AT, Wertheim-van Dillen PME, van Lier RAW, ten Berge IJM. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J IMMUNOL 2004;173(3):1834-1841.   [ PubMed ]

2003

• Gamadia LE. T cell development in human cytomegalovirus infection. S.l.: s.n.; 2003. (108pp.) (ISBN 90 5170 723 1) (PhD thesis. Supervisor(s): ten Berge RJM, van Lier RAW)   [ UvA Dissertations Online ]
• Gamadia LE, Remmerswaal EBM, Weel JF, Bemelman F, van Lier RAW, ten Berge IJM. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. BLOOD 2003;101(7):2686-2692.   [ PubMed ]
• Meijer RT, Surachno S, Yong SL, Bemelman FJ, Florquin S, ten Berge IJM, Schellekens PTA. Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody. CLIN EXP IMMUNOL 2003;133(3):485-492.   [ PubMed ]
• Roelofs JJTH, Rowshani AT, van den Berg JG, Claessen N, Aten J, ten Berge IJM, Weening JJ, Florquin S. Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection. KIDNEY INT 2003;64(5):1845-1853.   [ PubMed ]
• van Lier RAW, ten Berge IJM, Gamadia LE. Human CD8(+) T-cell differentiation in response to viruses. NAT REV IMMUNOL 2003;3(12):931-939.   [ PubMed ]
• van Sandick JW, Boermeester MA, Gisbertz SS, ten Berge IJM, Out TA, van der Pouw Kraan TCTM, van Lanschot JJB. Lymphocyte subsets and T(h)1/T(h)2 immune responses in patients with adenocarcinoma of the oesophagus or oesophagogastric junction: relation to pTNM stage and clinical outcome. CANCER IMMUNOL IMMUN 2003;52(10):617-624.   [ PubMed ]
• van Sandick JW, Gisbertz SS, ten Berge IJM, Boermeester MA, van der Pouw Kraan TCTM, Out TA, Obertop H, van Lanschot JJB. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. ANN SURG 2003;237(1):35-43.   [ PubMed ]

2002

• Bemelman FJ, Yong S, Parlevliet KJ, Surachno S, Schellekens PTA, ten Berge RJM. No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients. TRANSPL P 2002;34(8):3165-3167.   [ PubMed ]
• Boom R, Sol CJA, Schuurman T, van Breda A, Weel JFL, Beld M, ten Berge IJM, Wertheim-van Dillen PME, de Jong MD. Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented. J CLIN MICROBIOL 2002;40(11):4105-4113.   [ PubMed ]
• Bos IGA, ten Berge IJM, Hack CE. Role of complement in graft rejection after organ transplantation. TRANSFUS MED REV 2002;16(3):251-264.   [ PubMed ]
• de Metz J , Romijn JA, Gouma DJ, ten Berge IJM, Busch ORC, Endert E, Sauerwein HP. Interferon-gamma administration does not affect human thyroid hormone metabolism in the post-surgical euthyroid sick syndrome. J ENDOCRINOL INVEST 2002;25(4):315-320.   [ PubMed ]
• de Metz J , Sauerwein HP, Gouma DJ, Out TA, Reijneke RMR, Hack CE, Romijn JA, ten Berge IJM. Interferon-gamma administration to patients after major surgery influences cellular immunity without pro-inflammatory response. EUR J CLIN INVEST 2002;32(10):787-789.   [ PubMed ]
• Gamadia LE, ten Berge IJM, Picker LJ, van Lier RAW. Skewed maturation of virus-specific CTLs?. NAT IMMUNOL 2002;3(3):203.   [ PubMed ]
• Heydendael VMR, Spuls PI, ten Berge IJM, Opmeer BC, Bos JD, de Rie MA. Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels. BRIT J DERMATOL 2002;147(1):122-129.   [ PubMed ]
• Meijer RT, Koopmans RP, ten Berge IJM, Schellekens PTA. Pharmacokinetics of murine anti-human CD3 antibodies in man are determined by the disappearance of target antigen. J PHARMACOL EXP THER 2002;300(1):346-353.   [ PubMed ]
• Rentenaar RJ, van Diepen FNJ, Meijer RT, Surachno S, Wilmink JM, Schellekens PTA, Pals ST, van Lier RAW, ten Berge IJM. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. KIDNEY INT 2002;62(1):319-328.   [ PubMed ]
• Rentenaar RJ, Vosters JLG, van Diepen FNJ, Remmerswaal EBM, van Lier RAW, ten Berge IJM. Differentiation of human alloreactive CD8(+) T cells in vitro. IMMUNOLOGY 2002;105(3):278-285.   [ PubMed ]
• ten Berge RJM. Treatment of autoimmune diseases and vasculitides with immunosuppressive drugs. NETH J MED 2002;60(7):298-299.   [ PubMed ]
• van Leeuwen EM, Gamadia LE, Baars PA, Remmerswaal EB, ten Berge IJ, van Lier RA. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells. J IMMUNOL 2002;169(10):5838-5843.   [ PubMed ]

2001

• Davin JC, ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?. KIDNEY INT 2001;59(3):823-834.   [ PubMed ]
• de Metz J , Hack CE, Romijn JA, Levi M, Out TA, ten Berge IJ, Sauerwein HP. Interferon-gamma in healthy subjects: selective modulation of inflammatory mediators. EUR J CLIN INVEST 2001;31(6):536-543.   [ PubMed ]
• Gamadia LE, Rentenaar RJ, Baars PA, Remmerswaal EB, Surachno S, Weel JF, Toebes M, Schumacher TN, ten Berge IJ, van Lier RA. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. BLOOD 2001;98(3):754-761.   [ PubMed ]
• Gamadia LE, Rentenaar RJ, Remmerswaal EB, Surachno S, Weel JF, Toebes M, Schumacher TN, van Lier RA, ten Berge IJ. CMV-specific CD8(pos) T lymphocyte differentiation in latent CMV infection. TRANSPL P 2001;33(1-2):1802-1803.   [ PubMed ]
• Meijer RT, Keur I, Surachno S, ten Berge IJ, Schellekens PT. OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation. TRANSPL P 2001;33(3):2196-2197.   [ PubMed ]
• Meijer RT, Yong SL, Surachno S, ten Berge IJ, Schellekens PT. Treatment of acute kidney allograft rejection with the nonmitogenic CD3 mAb CLB T3/4.A (IgA-CD3): absence of a correlation of clinical responsiveness with inhibition of lymphocyte reactivity in vitro. TRANSPL P 2001;33(1-2):1229-1230.   [ PubMed ]
• Meijer RT, Yong SL, ten Berge IJ, van Lier RA, Schellekens PT. Non FcR-binding murine antihuman CD3 monoclonal antibody is capable of productive TCR signalling and induces proliferation in the presence of costimulation. CLIN EXP IMMUNOL 2001;123(3):511-519.   [ PubMed ]
• Rentenaar RJ, de Metz J , Bunders M, Wertheim-van Dillen PM, Gouma DJ, Romijn JA, Sauerwein HP, ten Berge IJ, van Lier RA. Interferon-gamma administration after abdominal surgery rescues antigen-specific helper T cell immune reactivity. CLIN EXP IMMUNOL 2001;125(3):401-408.   [ PubMed ]
• Rentenaar RJ, Gamadia LE, van der Hoek N, van Diepen FN, Boom R, Weel JF, van Lier RA, ten Berge IJ. CD4(+) T-cell dynamics in primary cytomegalovirus infection. TRANSPL P 2001;33(3):2313-2314.   [ PubMed ]
• Rentenaar RJ, Gamadia LE, van der Hoek N, van Diepen FN, Wertheim-van Dillen PM, Weel JF, Surachno S, van Lier RA, ten Berge IJ. CD8(POS) lymphocyte dynamics in primary CMV infection. TRANSPL P 2001;33(1-2):1867-1869.   [ PubMed ]
• Rentenaar RJ, Vosters JL, van Lier RA, ten Berge IJ. Detection of allospecific T cells by intracellular cytokine staining and flowcytometry. TRANSPL P 2001;33(1-2):426-427.   [ PubMed ]
• ten Berge IJ, Gamadia LE, Remmerswaal EB, Surachno S, Weel JF, Toebes M, Schumacher TN, van Lier RA. Differentiation of CMV-specific CD8(POS) T lymphocytes in primary CMV infection after renal transplantation. TRANSPL P 2001;33(7-8):3630.   [ PubMed ]
• van Kampen CA, Versteeg-van der Voort Maarschalk MF, Roelen DL, ten Berge IJ, Claas FH. Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens. TRANSPLANTATION 2001;71(7):869-874.   [ PubMed ]
• van Praag RM, Prins JM, Roos MT, Schellekens PT, ten Berge IJ, Yong SL, Schuitemaker H, Eerenberg AJ, Jurriaans S, de Wolf F, Fox CH, Goudsmit J, Miedema F, Lange JM. OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. J CLIN IMMUNOL 2001;21(3):218-226.   [ PubMed ]

2000

• Aten J, Roos A, Claessen N, Schilder-Tol EJ, ten Berge IJ, Weening JJ. Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J AM SOC NEPHROL 2000;11(8):1426-1438.   [ PubMed ]
• Bemelman FJ, Surachno S, ten Berge RJ. Immunologie in de medische praktijk. XXX. Orgaantransplantatie: indicaties en resultaten. NED TIJDSCHR GENEESKD 2000;144(30):1432-1436.   [ PubMed ]
• Rentenaar RJ, Gamadia LE, van DerHoek N, van Diepen FN, Boom R, Weel JF, Wertheim-van Dillen PM, van Lier RA, ten Berge IJ. Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J CLIN INVEST 2000;105(4):541-548.   [ PubMed ]
• Verbon A, Juffermans NP, Speelman P, van Deventer SJ, ten Berge IJ, Guchelaar HJ, van der Poll T. A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans. ANTIMICROB AGENTS CH 2000;44(9):2286-2290.   [ PubMed ]

1999

• Davin JC, Gruppen M, Bouts AH , Groothoff JW, van Amstel SP, Surachno J, ten Berge IJ, Weening JJ. Relapse of atypical haemolytic uraemic syndrome after kidney transplantation: role of ATG and failure of mycophenolate mofetil as rescue therapy. NEPHROL DIAL TRANSPL 1999;14(4):984-987.   [ PubMed ]
• de Metz J , Out TA, Wever PC, Reijneke RM, Sprangers F, Sauerwein HP, Romijn JA, ten Berge IJ. Interferon-gamma preferentially reduces memory/effector CD8 T lymphocytes in healthy subjects. J LAB CLIN MED 1999;134(2):147-153.   [ PubMed ]
• de Metz J , Sprangers F, Endert E, Ackermans MT, ten Berge IJ, Sauerwein HP, Romijn JA. Interferon-gamma has immunomodulatory effects with minor endocrine and metabolic effects in humans. J APPL PHYSIOL 1999;86(2):517-522.   [ PubMed ]
• Enomoto DN, Mekkes JR, Bossuyt PM, Yong SL, Out TA, Hoekzema R, de Rie MA, Schellekens PT, ten Berge IJ, de Borgie CA, Bos JD. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J AM ACAD DERMATOL 1999;41(6):915-922.   [ PubMed ]
• Prins JM, Jurriaans S, van Praag RM, Blaak H, van Rij R, Schellekens PT, ten Berge IJ, Yong SL, Fox CH, Roos MT, de Wolf F, Goudsmit J, Schuitemaker H, Lange JM. Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy. AIDS 1999;13(17):2405-2410.   [ PubMed ]
• Rentenaar RJ, Wever PC, van Diepen FN, Schellekens PT, Wertheim PM, ten Berge IJ. CD4dullCD8bright double-positive T-lymphocytes have a phenotype of granzyme Bpos CD8pos memory T-lymphocytes. NEPHROL DIAL TRANSPL 1999;14(6):1430-1434.   [ PubMed ]
• ten Berge IJ, Parlevliet KJ, Raasveld MH, Buysmann S, Bemelman FJ, Schellekens PT. Guidelines for the optimal use of muromonab CD3 in transplantation. BIODRUGS 1999;11(4):277-284.   [ PubMed ]
• Wever PC, Spaeny LH, van der Vliet HJ, Rentenaar RJ, Wolbink AM, Surachno J, Wertheim PM, Schellekens PT, Hack CE, ten Berge IJ. Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. J INFECT DIS 1999;179(3):693-696.   [ PubMed ]

1998

• Rentenaar RJ, Wever PC, van Diepen FN, Out TA, Schellekens PT, ten Berge IJ. Concomitant detection by flow cytometry of the intragranular antigen granzyme B and the intranuclear antigen Ki-67 in peripheral blood mononuclear cells from healthy individuals and patients with acute CMV infection after renal transplantation. TRANSPL P 1998;30(8):3958-3959.   [ PubMed ]
• ten Berge IJ, Wever PC, Rentenaar RJ, Spaeny LH, Surachno J, Wertheim PM, Schellekens PT, Hack CE. Selective expansion of a peripheral blood CD8+ memory T cell subset expressing both granzyme B and L-selectin during primary viral infection in renal allograft recipients. TRANSPL P 1998;30(8):3975-3977.   [ PubMed ]
• ten Berge IJ, Wever PC, Wolbink AM, Surachno J, Wertheim PM, Spaeny LH, Hack CE. Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation. TRANSPL P 1998;30(8):3972-3974.   [ PubMed ]
• Vervoordeldonk SF, Doumaid K, Remmerswaal EB, ten Berge IJ, Wilmink JM, de Waal LP, Boog CJ. Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion. BRIT J HAEMATOL 1998;102(4):1004-1009.   [ PubMed ]
• Wever PC, Aten J, Rentenaar RJ, Hack CE, Koopman G, Weening JJ, ten Berge IJ. Apoptotic tubular cell death during acute renal allograft rejection. CLIN NEPHROL 1998;49(1):28-34.   [ PubMed ]
• Wever PC, Boonstra JG, Laterveer JC, Hack CE, van der Woude FJ, Daha MR, ten Berge IJ. Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. TRANSPLANTATION 1998;66(2):259-264.   [ PubMed ]
• Wever PC, van der Vliet HJ, Spaeny LH, Wolbink AM, van Diepen FN, Froelich CJ, Hack CE, ten Berge IJ. The CD8+ granzyme B+ T-cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells. IMMUNOLOGY 1998;93(3):383-389.   [ PubMed ]

1997

• Benner R, Hooijkaas H, ten Berge RJ. Immunologie in de medische praktijk. I. Inleiding. NED TIJDSCHR GENEESKD 1997;141(37):1767-1768.   [ PubMed ]
• Boonstra JG, Wever PC, Laterveer JC, Bruijn JA, van der Woude FJ, ten Berge IJ, Daha MR. Apoptosis of acinar cells in pancreas allograft rejection. TRANSPLANTATION 1997;64(8):1211-1213.   [ PubMed ]
• Buysmann S, Hack CE, van Diepen FN, Surachno J, ten Berge IJ. Administration of OKT3 as a two-hour infusion attenuates first-dose side effects. TRANSPLANTATION 1997;64(11):1620-1623.   [ PubMed ]
• Buysmann S, Schellekens PT, Tax WJ, ten Berge IJ. Different CD3/T cell receptor monoclonal antibodies have distinct capacities to induce adhesion of T lymphocytes to endothelium. J LAB CLIN MED 1997;130(1):91-101.   [ PubMed ]
• Enomoto DN, Schellekens PT, Yong SL, ten Berge IJ, Mekkes JR, Bos JD. Extracorporeal photochemotherapy (photopheresis) induces apoptosis in lymphocytes: a possible mechanism of action of PUVA therapy. PHOTOCHEM PHOTOBIOL 1997;65(1):177-180.   [ PubMed ]
• Koopman G, Wever PC, Ramkema MD, Bellot F, Reiss P, Keehnen RM, ten Berge IJ, Pals ST. Expression of granzyme B by cytotoxic T lymphocytes in the lymph nodes of HIV-infected patients. AIDS RES HUM RETROV 1997;13(3):227-233.   [ PubMed ]
• Lardy NM, van der Horst AR, ten Berge IJ, Surachno S, Wilmink JM, de Waal LP. Influence of HLA-DRB1* incompatibility on the occurrence of rejection episodes and graft survival in serologically HLA-DR-matched renal transplant combinations. TRANSPLANTATION 1997;64(4):612-616.   [ PubMed ]
• Stronkhorst A, Radema S, Yong SL, Bijl H, ten Berge IJ, Tytgat GN, van Deventer SJ. CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study. GUT 1997;40(3):320-327.   [ PubMed ]
• ten Berge RJ, Buysmann S, van Diepen FN, Surachno S, Pals ST. Increased expression of ICAM-1 and VCAM-1 in the skin after administration of the first dose of OKT3. TRANSPL P 1997;29(1-2):325-327.   [ PubMed ]
• ten Berge RJ, Schellekens PT. Immunologie in de medische praktijk. VI. Nieuwe immunosuppressieve geneesmiddelen. NED TIJDSCHR GENEESKD 1997;141(47):2289-2292.   [ PubMed ]
• van der Vliet HJ, Wever PC, van Diepen FN, Yong SL, ten Berge IJ. Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis. CLIN EXP IMMUNOL 1997;110(2):324-328.   [ PubMed ]
• Wever PC, Mulder JB, Weening JJ, ten Berge IJ. Immunocytochemical detection of granzymes A and B in peripheral blood lymphocytes from healthy individuals after non-enzymatic antigen retrieval. J HISTOCHEM CYTOCHEM 1997;45(3):467-469.   [ PubMed ]

1996

• Buysmann S, Bemelman FJ, Schellekens PT, van Kooyk Y, Figdor CG, ten Berge IJ. Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. BLOOD 1996;87(1):404-411.   [ PubMed ]
• Buysmann S, van Diepen FN, Surachno S, Pals ST, ten Berge RJ. Increased dermal expression of ICAM-1 and VCAM-1 after administration of OKT3 in man. CLIN NEPHROL 1996;46(2):84-91.   [ PubMed ]
• Snijders F, Wever PC, Danner SA, Hack CE, ten Kate FJ, ten Berge IJ. Increased numbers of granzyme-B-expressing cytotoxic T-lymphocytes in the small intestine of HIV-infected patients. J ACQUIR IMMUNE DEFIC SYNDR HUM RETROVIROL 1996;12(3):276-281.   [ PubMed ]
• ten Berge RJ, Buysmann S, van Diepen FN, Surachno S, Hack CE. Consequences of OKT3 administration via continuous infusion as compared to bolus infusion. TRANSPL P 1996;28(6):3217-3220.   [ PubMed ]
• ten Berge RJ, Melief CJ. De Nobelprijs Geneeskunde 1996 voor de ontdekking van 'MHC-restrictie'. NED TIJDSCHR GENEESKD 1996;140(52):2607-2610.   [ PubMed ]
• van Twuyver E, de Hoop J, ten Berge RJ, Wilmink JM, Lems SP, van de Berg AP, Slooff MJ, de Waal LP. Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world. TRANSPLANTATION 1996;61(9):1392-1397.   [ PubMed ]
• Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J IMMUNOL 1996;157(1):473-479.   [ PubMed ]

1995

• Bemelman FJ, Buysmann S, Yong SL, van Diepen FN, Schellekens PT, ten Berge RJ. Biphasic granulocytopenia after administration of the first dose of OKT3. J LAB CLIN MED 1995;126(6):571-579.   [ PubMed ]
• Buysmann S, van Diepen FN, Yong SL, Surachno S, Schellekens PT, ten Berge RJ. Mechanism of lymphocytopenia following administration of corticosteroids. TRANSPL P 1995;27(1):871-872.   [ PubMed ]
• Kummer JA, Wever PC, Kamp AM, ten Berge IJ, Hack CE, Weening JJ. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. KIDNEY INT 1995;47(1):70-77.   [ PubMed ]
• Munson JL, van Twuyver E, Mooijaart RJ, Roux E, ten Berge IJ, de Waal LP. Missing T-cell receptor V beta families following blood transfusion. The role of HLA in development of immunization and tolerance. HUM IMMUNOL 1995;42(1):43-53.   [ PubMed ]
• Parlevliet KJ, Bemelman FJ, Yong SL, Hack CE, Surachno J, Wilmink JM, ten Berge IJ, Schellekens PT. Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients. TRANSPL INT 1995;8(2):141-146.   [ PubMed ]
• Parlevliet KJ, Chamuleau ME, Yong SL, Raasveld MH, ten Berge IJ, Schellekens PT. Effects of anti-CD3 monoclonal antibodies on functional activity of lymphocytes: studies in vivo and in vitro. CLIN EXP IMMUNOL 1995;99(2):155-159.   [ PubMed ]
• Zemel D, Struijk DG, Dinkla C, Stolk LM, ten Berge IJ, Krediet RT. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. J LAB CLIN MED 1995;126(2):204-215.   [ PubMed ]

1994

• Bemelman FJ, Buysmann S, Surachno J, Wilmink JM, Schellekens PT, ten Berge IJ. Pretreatment with divided doses of steroids strongly decreases side effects of OKT3. KIDNEY INT 1994;46(6):1674-1679.   [ PubMed ]
• Bemelman FJ, Buysmann S, Wilmink JM, Surachno S, Hack CE, Schellekens PT, ten Berge RJ. Effects of divided doses of steroids on side effects, cytokines, and activation of complement and granulocytes, coagulation and fibrinolysis after OKT3. TRANSPL P 1994;26(6):3096-3097.   [ PubMed ]
• Bemelman FJ, Jansen J, van der Poll T, Hack CE, van Deventer SJ, ten Berge RJ. Increased levels of sTNF receptors following OKT3 treatment. TRANSPL P 1994;26(6):3094-3095.   [ PubMed ]
• Bemelman FJ, Jansen J, van der Poll T, van Deventer SJ, ten Berge RJ. Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3. NEPHROL DIAL TRANSPL 1994;9(12):1786-1790.   [ PubMed ]
• Bemelman FJ, Parlevliet KJ, Schellekens PT, Surachno S, van Royen EA, ten Berge RJ. Sequestration of labelled granulocytes in the lungs following administration of OKT3 is dose-dependent. TRANSPL IMMUNOL 1994;2(1):47-51.   [ PubMed ]
• Buysmann S, van Diepen FN, van Kooyk Y, ten Berge RJ. The influence of OKT3 on expression of lymphocyte adhesion molecules in vitro. TRANSPL P 1994;26(6):3249-3250.   [ PubMed ]
• Parlevliet KJ, ten Berge IJ, Yong SL, Surachno J, Wilmink JM, Schellekens PT. In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants. J CLIN INVEST 1994;93(6):2519-2525.   [ PubMed ]
• Parlevliet KJ, ten Berge RJ, Raasveld MH, Surachno J, Wilmink JM, Schellekens PT. Low-dose OKT3 induction therapy following renal transplantation: a controlled study. NEPHROL DIAL TRANSPL 1994;9(6):698-703.   [ PubMed ]
• ten Berge IJ, Parlevliet KJ, Yong SL, Surachno J, Wilmink JM, Schellekens PT. Toxicity of IgA anti-CD3 isotype switch variant in vivo. TRANSPL P 1994;26(6):3150.   [ PubMed ]
• ten Berge RJ, Schellekens PT. Immunosuppressive drugs in clinical medicine. NETH J MED 1994;45(6):329-338.   [ PubMed ]
• van Twuyver E, Mooijaart RJ, ten Berge IJ, van der Horst AR, Wilmink JM, Claas FH, de Waal LP. High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion--the other side of the coin. TRANSPLANTATION 1994;57(8):1246-1251.   [ PubMed ]
• Zemel D, Krediet RT, Koomen GC, Kortekaas WM, Geertzen HG, ten Berge RJ. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. NEPHROL DIAL TRANSPL 1994;9(2):169-174.   [ PubMed ]

1993

• Raasveld MH, Bemelman FJ, Schellekens PT, van Diepen FN, van Dongen A, van Royen EA, Hack CE, ten Berge IJ. Complement activation during OKT3 treatment: a possible explanation for respiratory side effects. KIDNEY INT 1993;43(5):1140-1149.   [ PubMed ]
• Raasveld MH, Bloemena E, Wertheim-van Dillen P, Surachno J, Wilmink JM, ten Berge IJ. Serum neopterin/creatinine values correlate with severity of symptoms caused by cytomegalovirus infection in renal transplant recipients. TRANSPL INT 1993;6(1):42-44.   [ PubMed ]
• Raasveld MH, Bloemena E, Wilmink JM, Surachno S, Schellekens PT, ten Berge RJ. Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study. TRANSPL INT 1993;6(2):89-94.   [ PubMed ]
• Raasveld MH, Weening JJ, Kerst JM, Surachno S, ten Berge RJ. Local production of interleukin-6 during acute rejection in human renal allografts. NEPHROL DIAL TRANSPL 1993;8(1):75-78.   [ PubMed ]
• ten Berge RJ, Raasveld MH, van Diepen FN, Hack CE. Activation of coagulation and fibrinolysis during treatment with OKT3. TRANSPL P 1993;25(1 Part 1):566-567.   [ PubMed ]
• Wolbink GJ, Bollen J, Baars JW, ten Berge RJ, Swaak AJ, Paardekooper J, Hack CE. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J IMMUNOL METHODS 1993;163(1):67-76.   [ PubMed ]
• Zemel D, Koomen GC, Hart AA, ten Berge IJ, Struijk DG, Krediet RT. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J LAB CLIN MED 1993;122(6):686-696.   [ PubMed ]
• Zemel D, ten Berge RJ, Koomen GC, Struijk DG, Krediet RT. Serum interleukin-6 in continuous ambulatory peritoneal dialysis in patients. NEPHRON 1993;64(2):320-321.   [ PubMed ]

1992

• Chamuleau ME, ten Berge IJ, Schellekens PT, Wilmink JM, Hintzen RQ, van Lier RA. Serum levels of soluble CD27 in renal transplant recipients. TRANSPLANTATION 1992;54(5):932-936.   [ PubMed ]
• Raasveld MH, Bloemena E, Surachno S, ten Berge RJ. T gamma/delta lymphocytes in renal transplant recipients. NEPHROL DIAL TRANSPL 1992;7(6):530-533.   [ PubMed ]
• Raasveld MH, Hack CE, ten Berge IJ. Activation of coagulation and fibrinolysis following OKT3 administration to renal transplant recipients: association with distinct mediators. THROMB HAEMOSTASIS 1992;68(3):264-267.   [ PubMed ]
• Raasveld MH, Surachno S, Hack CE, ten Berge RJ. Thromboembolic complications and dose of monoclonal OKT3 antibody. LANCET 1992;339(8805):1363-1364.   [ PubMed ]
• Zemel D, ten Berge RJ, Struijk DG, Bloemena E, Koomen GC, Krediet RT. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. CLIN NEPHROL 1992;37(2):97-103.   [ PubMed ]

1991

• de Wit R, Raasveld MH, ten Berge RJ, van der Wouw PA, Bakker PJ, Veenhof CH. Interleukin-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon-alpha. J INTERN MED 1991;229(6):539-542.   [ PubMed ]
• Hintzen RQ, de Jong R, Hack CE, Chamuleau M, de Vries EF, ten Berge IJ, Borst J, van Lier RA. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J IMMUNOL 1991;147(1):29-35.   [ PubMed ]
• van Twuyver E, Mooijaart RJ, ten Berge IJ, van der Horst AR, Wilmink JM, Kast WM, Melief CJ, de Waal LP. Pretransplantation blood transfusion revisited. NEW ENGL J MED 1991;325(17):1210-1213.   [ PubMed ]

1990

• Bloemena E, ten Berge IJ, Surachno J, Wilmink JM. Kinetics of interleukin 6 during OKT3 treatment in renal allograft recipients. TRANSPLANTATION 1990;50(2):330-331.   [ PubMed ]
• Parleviet KJ, Jonker M, ten Berge RJ, van Lier RA, Wilmink JM, Strengers PF, Aarden LA, Schellekens PT. Anti-CD3 murine monoclonal isotype switch variants tested for toxicity and immunologic monitoring in four chimpanzees. TRANSPLANTATION 1990;50(5):889-892.   [ PubMed ]

1988

• Braakman E, Treep-van Leeuwen P, ten Berge RJ, Schellekens PT, Lucas CJ. Role of IL-2 and interferon in the generation of natural cytotoxic activity in influenza virus-stimulated PBL cultures: analysis with the use of prednisolone. CLIN EXP IMMUNOL 1988;71(2):302-307.   [ PubMed ]

1987

• Oosterhuis B, ten Berge IJ, Schellekens PT, van Boxtel CJ. Concentration-dependent effects of prednisolone on lymphocyte subsets and mixed lymphocyte culture in humans. J PHARMACOL EXP THER 1987;243(2):716-722.   [ PubMed ]
• ten Berge RJ, Schellekens PT, Budding-Koppenol A, Dooren LJ, Vossen JM. Natural killer (NK)-cell activity in sorted subsets of peripheral blood mononuclear cells from patients with severe combined immunodeficiency. J CLIN IMMUNOL 1987;7(3):198-202.   [ PubMed ]

1986

• Oosterhuis B, ten Berge IJ, Schellekens PT, Koopmans RP, van Boxtel CJ. Prednisolone concentration-effect relations in humans and the influence of plasma hydrocortisone. J PHARMACOL EXP THER 1986;239(3):919-926.   [ PubMed ]

1985

• ten Berge IJ, Wilmink JM, Meyer CJ, Surachno J, ten Veen KH, Balk TG, Schellekens PT. Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis. AM J NEPHROL 1985;5(1):21-29.   [ PubMed ]
• ten Berge RJ, Schellekens PT, van Boxtel CJ, Sauerwein HP, Wilmink JM. The influence of immunosuppressive drugs on human immunocompetence. SCAND J UROL NEPHROL SUPPL 1985;92:3.   [ PubMed ]

1984

• Oosterhuis B, ten Berge RJ, Sauerwein HP, Endert E, Schellekens PT, van Boxtel CJ. Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man. J PHARMACOL EXP THER 1984;229(2):539-546.   [ PubMed ]
• Schellekens PT, ten Berge RJ. The effects of immunosuppressive drugs on human immunocompetence. PHARM WEEKBL SCI 1984;6(1):32-38.   [ PubMed ]
• ten Berge RJ, Sauerwein HP, Yong SL, Schellekens PT. Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes. CLIN IMMUNOL IMMUNOPATHOL 1984;30(1):91-103.   [ PubMed ]
• ten Berge RJ, Schellekens PT, Hamerlynck JV, Bruning PF. Combination chemotherapy and immune capacity in advanced ovarian carcinoma. EUR J CANCER CLIN ONCOL 1984;20(1):91-98.   [ PubMed ]

1983

• Prummel MF, ten Berge RJ, Barrowclough H, Cejka V. Kaposi-sarcoom en dodelijke opportunistische infecties bij een homoseksuele man met een deficiënt immuunapparaat. NED TIJDSCHR GENEESKD 1983;127(19):820-824.   [ PubMed ]
• ten Berge RJ, Natarajan AT, Hardeman MR, van Royen EA, Schellekens PT. Labeling with indium-111 has detrimental effects on human lymphocytes: concise communication. J NUCL MED 1983;24(7):615-620.   [ PubMed ]
• ten Berge RJ, Schellekens PT. A critical analysis of the use of azathioprine in clinical medicine. NETH J MED 1983;26(6):164-171.   [ PubMed ]

1982

• Jonkers RE, Oosterhuis B, ten Berge RJ, van Boxtel CJ. Analysis of 6-mercaptopurine in human plasma with a high-performance liquid chromatographic method including post-column derivatization and fluorimetric detection. J CHROMATOGR A 1982;233:249-255.   [ PubMed ]
• Rümke HC, Miedema F, ten Berge IJ, Terpstra F, van der Reijden HJ, van de Griend RJ, de Bruin HG, von dem Borne AE, Smit JW, Zeijlemaker WP, Melief CJ. Functional properties of T cells in patients with chronic T gamma lymphocytosis and chronic T cell neoplasia. J IMMUNOL 1982;129(1):419-426.   [ PubMed ]
• ten Berge RJ, Schellekens PT, Surachno S, The TH, ten Veen JH, Wilmink JM. A longitudinal study on the effects of azathioprine and high doses of prednisone on the immune system of kidney-transplant recipients. CLIN IMMUNOL IMMUNOPATHOL 1982;24(1):33-46.   [ PubMed ]
• ten Berge RJ, van Walbeek HK, Schellekens PT. Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis. CLIN EXP IMMUNOL 1982;50(3):495-502.   [ PubMed ]
• Thien SL, Catovsky D, Oscier D, Goldman JM, van der Reijden HJ, Melief CJ, Rümke HC, ten Berge RJ, von dem Borne AE. T-chronic lymphocytic leukaemia presenting as primary hypogammaglobulinaemia--evidence of a proliferation of T-suppressor cells. CLIN EXP IMMUNOL 1982;47(3):670-676.   [ PubMed ]
• van de Griend RJ, ten Berge I, Tanke HJ, Roos D, Schellekens PT, Melief CJ, Zeijlemaker WP, Astaldi A. Characterization of two subsets of human T gamma cells. J IMMUNOL 1982;128(5):1979-1985.   [ PubMed ]

1981

• ten Berge RJ, Schellekens PT, Surachno S, The TH, ten Veen JH, Wilmink JM. The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients. CLIN IMMUNOL IMMUNOPATHOL 1981;21(1):20-32.   [ PubMed ]